Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sodium butyrate exerts protective effect against Parkinson's disease in mice via stimulation of glucagon like peptide-1
Jiaming Liu, Fangyan Wang, Suzhi Liu, et al.
Journal of the Neurological Sciences (2017) Vol. 381, pp. 176-181
Closed Access | Times Cited: 178

Showing 1-25 of 178 citing articles:

The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
Ygor Parladore Silva, Andressa Bernardi, Rudimar Luiz Frozza
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 1972
Fecal microbiota transplantation alleviated Alzheimer’s disease-like pathogenesis in APP/PS1 transgenic mice
Jing Sun, Jing‐Xuan Xu, Yi Ling, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 395
The blood-brain barrier in aging and neurodegeneration
Emily G. Knox, María R. Aburto, Gerard Clarke, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 6, pp. 2659-2673
Open Access | Times Cited: 386
Short chain fatty acids: Microbial metabolites for gut-brain axis signalling
Kenneth J. O’Riordan, Michael Collins, Gerard M. Moloney, et al.
Molecular and Cellular Endocrinology (2022) Vol. 546, pp. 111572-111572
Open Access | Times Cited: 309
Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders
Jeffrey J. Lochhead, Junzhi Yang, Patrick T. Ronaldson, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 304
Butyrate and the Intestinal Epithelium: Modulation of Proliferation and Inflammation in Homeostasis and Disease
Pooja S. Salvi, Robert A. Cowles
Cells (2021) Vol. 10, Iss. 7, pp. 1775-1775
Open Access | Times Cited: 290
Role of microbiota-derived short-chain fatty acids in nervous system disorders
Rasoul Mirzaei, Behnaz Bouzari, Seyed Reza Hosseini‐Fard, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 139, pp. 111661-111661
Open Access | Times Cited: 271
Microbiota and the gut-brain-axis: Implications for new therapeutic design in the CNS
Longsha Liu, Jun R. Huh, Khalid Shah
EBioMedicine (2022) Vol. 77, pp. 103908-103908
Open Access | Times Cited: 215
Effect of Clostridium butyricum against Microglia‐Mediated Neuroinflammation in Alzheimer's Disease via Regulating Gut Microbiota and Metabolites Butyrate
Jing Sun, Jing‐Xuan Xu, Bo Yang, et al.
Molecular Nutrition & Food Research (2019) Vol. 64, Iss. 2
Closed Access | Times Cited: 210
Interplay of gut microbiota and oxidative stress: Perspective on neurodegeneration and neuroprotection
Shruti Shandilya, Sandeep Kumar, Niraj Kumar Jha, et al.
Journal of Advanced Research (2021) Vol. 38, pp. 223-244
Open Access | Times Cited: 190
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Qing Wang, Yuqi Luo, К. Ray Chaudhuri, et al.
Brain (2021) Vol. 144, Iss. 9, pp. 2571-2593
Open Access | Times Cited: 189
Gut microbiota and aging
Zongxin Ling, Xia Liu, Yiwen Cheng, et al.
Critical Reviews in Food Science and Nutrition (2020) Vol. 62, Iss. 13, pp. 3509-3534
Closed Access | Times Cited: 187
Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson’s disease via gut microbiota-GLP-1 pathway
Jing Sun, Haijun Li, Yangjie Jin, et al.
Brain Behavior and Immunity (2020) Vol. 91, pp. 703-715
Closed Access | Times Cited: 178
Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity
Sunil Srivastav, Sabita Neupane, Sunil Bhurtel, et al.
The Journal of Nutritional Biochemistry (2019) Vol. 69, pp. 73-86
Closed Access | Times Cited: 164
Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling
Sevag Hamamah, Armin Aghazarian, Anthony Nazaryan, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 436-436
Open Access | Times Cited: 158
Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson’s disease
Yan-fang Hou, Chang Shan, Si-yue Zhuang, et al.
Microbiome (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 150
Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle
Saravana Babu Chidambaram, Musthafa Mohamed Essa, Annan Gopinath Rathipriya, et al.
Pharmacology & Therapeutics (2021) Vol. 231, pp. 107988-107988
Open Access | Times Cited: 124
Mechanisms of Blood–Brain Barrier Protection by Microbiota-Derived Short-Chain Fatty Acids
Ekaterina Fock, Parnova Rg
Cells (2023) Vol. 12, Iss. 4, pp. 657-657
Open Access | Times Cited: 120
Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease
Manlian Zhu, Xia Liu, Yiru Ye, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 111
The function of gut microbiota in immune-related neurological disorders: a review
Panida Sittipo, Jaeyoon Choi, Soojin Lee, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 109
Short chain fatty acids: key regulators of the local and systemic immune response in inflammatory diseases and infections
Lisa-Marie Ney, Maximilian Wipplinger, Martha Grossmann, et al.
Open Biology (2023) Vol. 13, Iss. 3
Open Access | Times Cited: 105
Antidiabetic agents as a novel treatment for Alzheimer’s and Parkinson’s disease
Joseph Nowell, Eleanor G Blunt, Dhruv Gupta, et al.
Ageing Research Reviews (2023) Vol. 89, pp. 101979-101979
Open Access | Times Cited: 84
Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms
Ao‐Ji Xie, Elizabeth Ensink, Peipei Li, et al.
Movement Disorders (2022) Vol. 37, Iss. 8, pp. 1644-1653
Open Access | Times Cited: 79
Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: Relevance to Parkinson's disease and therapeutic implications
Balaraman Kalyanaraman, Gang Cheng, Micaël Hardy
Redox Biology (2024) Vol. 71, pp. 103092-103092
Open Access | Times Cited: 38
Gut Microbiota-Based Interventions for Parkinson’s Disease: Neuroprotective Mechanisms and Current Perspective
Deepak Kumar, Mahendra Bishnoi, Kanthi Kiran Kondepudi, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top